Evidence map›Paper›PMID 33117390›Full record

ArticleFrontiers in immunology2020

Julia Uebele, Katharina Habenicht, Olga Ticha, Isabelle Bekeredjian-Ding

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Immunoengineering: An Emerging Field in Infectious Diseases.The Journal of infectious diseases · 2025
    Review
  3. Article
  4. Article
  5. LinkingAntibiotics (Basel, Switzerland) · 2024
    Review
  6. The immune evasion roles ofFrontiers in cellular and infection microbiology · 2023
    Review
  7. Article
  8. Article
  9. Frontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Julia UebeleDivision of Microbiology, Paul-Ehrlich-Institut, Langen, Germany.
Katharina HabenichtDivision of Microbiology, Paul-Ehrlich-Institut, Langen, Germany.
Olga TichaDivision of Microbiology, Paul-Ehrlich-Institut, Langen, Germany.
Isabelle Bekeredjian-DingDivision of Microbiology, Paul-Ehrlich-Institut, Langen, Germany.
Paul Ehrlich Institut · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite continuous exposure and development of specific immunity,

Indexed as

Antigen-Presenting CellsAntigens, BacterialCells, CulturedEpitopes, T-LymphocyteHumansImmune ToleranceLeukocytes, MononuclearStaphylococcal InfectionsStaphylococcus aureusT-Lymphocytes, RegulatoryAntigens, BacterialEpitopes, T-Lymphocytestreptococcal protective antigenhumanIg-binding proteinsimmune evasionimmune suppressionprotein AStaphylococcus aureustoleranceTreg—regulatory T cell

Identifiers

PMID33117390
PMCPMC7560526
OpenAlexW3091306062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.